Pregenetic Implantation Screening (PGS) is a genetic test designed to increase the chance of In Vitro Fertilization (IVF) success. The test is performed on embryos resulting from a successful IVF treatment cycle.
The amount of genetic material within IVF embryos is examined, looking for misplaced (called translocation) or an incorrect number (called aneuploid) of chromosomes. These embryos do not typically result in a successful pregnancy, but could lead to the birth of a child with a severe genetic condition.
Conversely, PGS testing will allow our embryologist to select only embryos with the correct number of chromosomes, also called euploid embryos, for transfer into the uterus. Euploid embryos have much better chances to implant in the uterus and grow into a healthy baby girl or boy, and zero chances at being born with a genetic condition
All women are capable of producing embryos with chromosomal abnormalities. The likelihood increases with age however, regardless of the number of embryos produced. Read more about age and infertility.
There are many benefits to combining PGS with IVF.
- Increased Chance of Pregnancy
- Decreased Chance of Miscarriage
- Reduced Number of IVF Cycles Necessary
- Faster Track to Family Growth
- Gender Identification
- Eliminated Possibility of Genetic Disorders
- Increases Success Rates for Single Embryo Transfers
If you, or someone you know, is thinking about utilizing In Vitro Fertilization (IVF) to have a child, be sure to also ask about the benefits of PGS. Or, submit your questions by email. Dr Morgan or a lead nurse will be happy to discuss your options.